ABOUT THIS PODCAST
BiTEs or bispecific T-cell engager antibodies are an emerging class of therapies with significant potential to advance cancer treatment. Pharmacists will play a key role both in the utilization of these agents but also in the mitigation and management of the unique toxicities that accompany them. This podcast provides insights into the patient care needs and novel interdisciplinary models employed to support patients receiving BiTE therapies. Listeners will gain key insights into BiTE therapies, including their role in treatment, the current pipeline, and safety considerations.
SHOW NOTES
SPEAKERS
- Kayla Waldron, PharmD, MS, BCPS, FASHP
Director, Medication Use and Quality Improvement, ASHP - Alexandra Wolff, PharmD, BCOP, FHOPA
Clinical Pharmacy Specialist, Atrium Health/Advocate Health
